Resultados de procura - Emilio A. Emini

Limitar resultados
  1. 1
    Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization

    Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization por Emilio A. Emini, Philomena Ostapchuk, Eckard Wimmer

    Publicado 1983
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C

    Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C por S Pincus, David C. Diamond, Emilio A. Emini, Eckard Wimmer

    Publicado 1986
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide

    Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide por Emilio A. Emini, J V Hughes, Debra S. Perlow, Joshua Boger

    Publicado 1985
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    A novel assay for the DNA strand-transfer reaction of HIV-1 integrase

    A novel assay for the DNA strand-transfer reaction of HIV-1 integrase por Daria J. Hazuda, Jeffrey C. Hastings, Abigail Wolfe, Emilio A. Emini

    Publicado 1994
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies

    Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies por Emilio A. Emini, S Y Kao, Angela Lewis, R Crainic, Eckard Wimmer

    Publicado 1983
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies

    Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies por Emilio A. Emini, Bradford A. Jameson, Angela Lewis, G R Larsen, Eckard Wimmer

    Publicado 1982
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy

    Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy por Jon H. Condra, Christos J. Petropoulos, Rainer Ziermann, William A. Schleif, Malathi Shivaprakash, Emilio A. Emini

    Publicado 2000
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody

    Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody por Miroslaw K. Górny, Alan J. Conley, S Karwowska, Aby Buchbinder, Jiake Xu, Emilio A. Emini, Scott Koenig, Susan Zolla‐Pazner

    Publicado 1992
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

    Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. por Alan J. Conley, Joseph Kessler, L J Boots, J S Tung, Beth Arnold, Paul M. Keller, Alan Shaw, Emilio A. Emini

    Publicado 1994
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors

    Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors por Jon H. Condra, Emilio A. Emini, L Gotlib, Donald J. Graham, A J Schlabach, Jill Wolfgang, Richard J. Colonno, Vinod Sardana

    Publicado 1992
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Active human immunodeficiency virus protease is required for viral infectivity.

    Active human immunodeficiency virus protease is required for viral infectivity. por Nancy E. Kohl, Emilio A. Emini, William A. Schleif, Lenora J. Davis, Jill C. Heimbach, Richard A. Dixon, Edward M. Scolnick, Irving S. Sigal

    Publicado 1988
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.

    Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors. por Vinod Sardana, Emilio A. Emini, L Gotlib, Donald J. Graham, D W Lineberger, William J. Long, A J Schlabach, Jill Wolfgang, Jon H. Condra

    Publicado 1992
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure

    Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure por Joseph K. Wong, Huldrych F. Günthard, Diane V. Havlir, Zhi‐Qiang Zhang, Ashley T. Haase, Caroline Ignacio, Shirley Kwok, Emilio A. Emini, Douglas D. Richman

    Publicado 1997
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors

    Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors por Jack H. Nunberg, William A. Schleif, Evelyn Boots, J A O'Brien, J C Quintero, J. M. HOFFMAN, Emilio A. Emini, Mark E. Goldman

    Publicado 1991
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

    Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells por Robert L. LaFemina, Christine L. Schneider, Helen L. Robbins, P L Callahan, K LeGrow, E. Jill Roth, William A. Schleif, Emilio A. Emini

    Publicado 1992
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada

    Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers Given With Routine Pediatric Vaccinations in Canada por Otto G. Vanderkooi, David W. Scheifele, Douglas Girgenti, Scott A. Halperin, Scott D. Patterson, William C. Gruber, Emilio A. Emini, Daniel A. Scott, James D. Kellner

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

    Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees por Emilio A. Emini, Peter L. Nara, William A. Schleif, John A. Lewis, J P Davide, D R Lee, Joseph Kessler, S Conley, Shuzo Matsushita, Scott D. Putney

    Publicado 1990
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

    Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D por Alan J. Conley, Miroslaw K. Górny, Joseph Kessler, L J Boots, M Ossorio-Castro, Scott Koenig, D W Lineberger, Emilio A. Emini, Constance Williams, Susan Zolla‐Pazner

    Publicado 1994
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine por Lisa A. Jackson, Alejandra Gurtman, Kathryn Rice, Karlis Pauksens, Richard N. Greenberg, Thomas R. Jones, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

    Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults por Lisa A. Jackson, Alejandra Gurtman, Martin van Cleeff, Kathrin U. Jansen, Deepthi Jayawardene, Carmel Devlin, Daniel A. Scott, Emilio A. Emini, William C. Gruber, Beate Schmöele-Thoma

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: